# Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples

> **NCT00629577** · PHASE1 · TERMINATED · sponsor: **British Columbia Cancer Agency** · enrollment: 50 (estimated)

## Conditions studied

- Cervical Cancer
- Precancerous Condition

## Interventions

- **GENETIC:** microarray analysis
- **OTHER:** flow cytometry
- **PROCEDURE:** biopsy
- **PROCEDURE:** colposcopy

## Key facts

- **NCT ID:** NCT00629577
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2010-06
- **Final completion:** 2011-12
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** no funding
- **Last updated:** 2017-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00629577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00629577, "Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00629577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*